Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Median Technologies
Age
50–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
≥50-80 Years of age;
Current or ex-smoker (\>=20 pack years);
Patient screened and surveilled for lung cancer screening following lung cancer screening guidelines (equivalent to United States Preventive Services Task Force (USPSTF) 2021 Criteria);
Received LDCT due to inclusion in high-risk category for lung cancer.
You may not be if
Prior lung resection;
Pacemaker or other indwelling metallic medical devices in the thorax that interfere with CT acquisition;
Patients/images used during AI model development;
Patients with only hilar and/or mediastinal cancer(s);
Patients with only ground glass cancer(s);
Patients with nodules, solid or part-solid \>30mm (masses);
Patients that are not accompanied with the required clinical information;
Patients with imaging with any of the following: missing slices, slice thickness \>3mm;
Partial cover of the lung.
Clareo Health | Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)
